Back

Systolic Blood Pressure Variability and Major Adverse Outcomes in Patients with Atrial Fibrillation: the AFFIRM Study

28 August 2017 (14:15 - 14:30)
Organised by:
Congress Presentation Part of: Clinical Trial Update 1 Hypertension, other ESC Premium Access ESC Congress 2017

About the speaker

Photo
Associate Professor Marco Proietti

University of Milan, Milan (Italy)

5 More presentations in this session

Presentation thumbnail
Increased all-cause mortality with intensive blood-pressure control in patients with a baseline systolic blood pressure of >=160 mmHg and a Lower Framingham risk score: a cautionary note from SPRINT
Professor T. Wang (Taipei, TW)
Slides Video
Presentation thumbnail
Clinical Efficacy and Safety of Achieving Very Low LDL-C Levels With the PCSK9 Inhibitor Evolocumab in the FOURIER Outcomes Trial
Doctor R. Giugliano (Boston, US)
Slides Video
Presentation thumbnail
The long-term efficacy and safety of short dual antiplatelet therapy
Professor M. Nakamura (Tokyo, JP)
Slides Video
Presentation thumbnail
Mechanisms for the benefit of spironolactone in resistant hypertension in the PATHWAY-2 study
Professor B. Williams (London, GB)
Slides Video
Presentation thumbnail
Aldosterone Lethal Effects Blocked in Acute Myocardial Infarction Treated With or Without Reperfusion to Improve Outcome and Survival at Six Months Follow-up
Professor F. Beygui (Caen, FR)
Slides Video

Access the full session

Session thumbnail
Clinical Trial Update 1

The Event

Event poster

ESC Congress 2017

28 August 2017 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Systolic blood pressure visit-to-visit variability and outcomes in Asian patients with established or multiple risk factors for atherosclerotic cardiovascular disease: results from the CORE-Thailand
27 August 2023
thumbnail
Congress Presentation
Aspects of sympathetic and parasympathetic autonomic activation in patients with heart failure, mid-range left ventricular ejection fraction and atrial fibrillation
29 June 2021
thumbnail
Congress Session
Novel approaches: how to provide patient-centred atrial fibrillation care
28 August 2023
thumbnail
Congress Presentation
Isolated systolic hypertension versus combined systolic-diastolic hypertension as predictors of atrial fibrillation: Data from a 8-year-follow-up study
3 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources